AFYX is a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of mucosal diseases.
Business Model:
Revenue: $4.1M
Employees: 2-10
Address: Lergravsvej 57, 2. tv
City: København S
State: capital region
Zip: 2300
Country: DK
AFYX is a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of mucosal diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2019 | Grant | 1 | $81.9k |
EASME - EU Executive Agency for SMEs EASME - EU Executive Agency for SMEs |
6/2019 | Debt Financing | 2 | $13M |
Lundbeckfonden Emerge Novo Holdings Sofinnova Partners Lundbeckfonden Emerge Novo Holdings Sofinnova Partners |
5/2017 | Series A | 3 | $17.6M |
Lundbeckfonden Emerge Novo Holdings Sofinnova Investments Lundbeckfonden Emerge Novo Holdings Sofinnova Investments |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|